NCT06188728
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +3 more
- Locations
-
- The University of Agriculture Peshawar, Khyberpakhtunkhwa, Pakistan
Clinical trial condition
Hyperinsulinism
Explore clinical trials studying Hyperinsulinism. Study availability and eligibility vary by location and protocol.
3,702 public trials
361 recruiting studies
Hyperinsulinism trial results
Completed
Laser Efficiency on Metabolic Parameters
NCT06193746
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +3 more
- Locations
-
- Toka Cairo, Egypt
NCT01151605
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +2 more
- Locations
-
- Millard Fillmore Gates Hospital Buffalo, New York, United States
NCT06183801
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +3 more
- Locations
-
- Glac Biotech Co., Ltd. Tainan, Taiwan
NCT04186494
- Conditions
- Apnea, Dyssomnias, Glucose Metabolism Disorders, +11 more
- Locations
-
- St Vincent's University Hospital Dublin, Dublin 4, Ireland
NCT02798666
- Conditions
- Body Weight, Glucose Metabolism Disorders, Hyperinsulinism, +10 more
- Locations
-
Not specified
NCT03777176
- Conditions
- Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +7 more
- Locations
-
- Children's Hospital of Colorado Aurora, Colorado, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
- Cook Children's Medical Center Fort Worth, Texas, United States
- University Hospital Düsseldorf, Department of Pediatrics Düsseldorf, Germany
NCT00242814
- Conditions
- Cardiovascular Diseases, Glucose Metabolism Disorders, Hyperinsulinism, +7 more
- Locations
-
- 502.486.3302A Cabinet Médical Angers, France
- 502.486.3302B Cabinet Médical Angers, France
- 502.486.3303A Boehringer Ingelheim Investigational Site Angers, France
- 502.486.3305A Cabinet Médical Angers, France
Completed
The Role of Vitamin E Incorporated Oat Supplementation in Metabolic Syndrome (MetS) Patients
NCT05604300
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +3 more
- Locations
-
- Advanced Medical and Dental Institute (AMDI) Kepala Batas, Pulau Pinang, Malaysia
Completed
Long-term Benefits of Abdominal Fat Loss in Abdominally Obese Dyslipidemic Patients (SYNERGIE Study)
NCT06158191
- Conditions
- Behavior, Body Weight, Cardiometabolic Syndrome, +18 more
- Locations
-
Not specified